139
Participants
Start Date
December 18, 2018
Primary Completion Date
January 3, 2023
Study Completion Date
February 2, 2023
KN046
"Phase Ia：Intravenous (IV) infusions, 1,3 and 5 milligrams per kilogram (mg/kg) every 2 weeks.~Phase Ib：Intravenous (IV) infusions, 1 ,3 or 3, 5 milligrams per kilogram (mg/kg) every 2 weeks, the dose of phase Ib based on the result of phase Ia."
Sun Yat-sen University Cancer Center, Guangzhou
Fujian Cancer Hospital, Fuzhou
Fujian Medical University Union Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
Sun Yat-sen University Cancer Center, Guangzhou
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
LINYI Cancer Hospital, Linyi
Shanghai East Hospital, Shanghai
Chengdu Seventh People's Hospital, Chengdu
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
INDUSTRY